A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia

被引：0
|
作者：
Amy Y. Wang
Howard Weiner
Margaret Green
Hua Chang
Noreen Fulton
Richard A. Larson
Olatoyosi Odenike
Andrew S. Artz
Michael R. Bishop
Lucy A. Godley
Michael J. Thirman
Satyajit Kosuri
Jane E. Churpek
Emily Curran
Kristen Pettit
Wendy Stock
Hongtao Liu
机构：
[1] University of Chicago Medicine,Internal Medicine/Pediatric Residency Program
[2] University of Chicago Medicine,Department of Medicine, Section of Hematology/Oncology
[3] Karyopharm Therapeutics Inc,Department of Medicine, Section of Hematology/Oncology
[4] University of Michigan Medicine,undefined
来源：
Journal of Hematology & Oncology | / 11卷
关键词：
AML; Selinexor; Induction chemotherapy; XPO1/CRM1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan
    Ikezoe, Takayuki
    Ando, Kiyoshi
    Onozawa, Masahiro
    Yamane, Takahisa
    Hosono, Naoko
    Morita, Yasuyoshi
    Kiguchi, Toru
    Iwasaki, Hiromi
    Miyamoto, Toshihiro
    Matsubara, Keisuke
    Sugimoto, Saori
    Miyazaki, Yasushi
    Kizaki, Masahiro
    Akashi, Koichi
    CANCER SCIENCE, 2022, 113 (12) : 4258 - 4266
  • [32] High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia
    Schlenk, RF
    Germing, U
    Hartmann, F
    Glasmacher, A
    Fischer, JT
    Fuentes, FDY
    Götze, K
    Pralle, H
    Nerl, C
    Salwender, H
    Grimminger, W
    Petzer, A
    Hensel, M
    Benner, A
    Zick, L
    Döhner, K
    Fröhling, S
    Döhner, H
    LEUKEMIA, 2005, 19 (06) : 978 - 983
  • [33] High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia
    R F Schlenk
    U Germing
    F Hartmann
    A Glasmacher
    J T Fischer
    F del Valle y Fuentes
    K Götze
    H Pralle
    C Nerl
    H Salwender
    W Grimminger
    A Petzer
    M Hensel
    A Benner
    L Zick
    K Döhner
    S Fröhling
    H Döhner
    Leukemia, 2005, 19 : 978 - 983
  • [34] A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia
    Bassan, R
    Lerede, T
    Buelli, M
    Borleri, G
    Bellavita, P
    Rambaldi, A
    Barbul, T
    HAEMATOLOGICA, 1998, 83 (05) : 422 - 427
  • [35] High-dose mercaptopurine and intermediate-dose cytarabine during first remission of acute myeloid leukemia
    Canpolat, C
    Jeha, S
    Lockhart, S
    Ramirez, I
    Zipf, T
    Pinkel, D
    CANCER INVESTIGATION, 1997, 15 (02) : 121 - 126
  • [36] Timed sequential therapy with high-dose cytarabine and mitoxantrone as an induction regimen for acute myeloid leukemia:An update on adverse events.
    Richardson, Kristin J.
    Kollipara, Revathi
    Katz, Deborah Ann
    Hoyt, Maura
    Gallas, Kirstin
    Venugopal, Parameswaran
    Larson, Melissa L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] HIGH-DOSE METHYLPREDNISOLONE FOR REMISSION INDUCTION IN HYPOPLASTIC ACUTE MYELOID-LEUKEMIA
    HICSONMEZ, G
    CETIN, M
    TUNCER, MA
    GUMRUK, F
    OZBEK, N
    KARA, A
    GURGEY, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (02) : 125 - 126
  • [38] High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk Acute Myeloid Leukemia (AML)
    Larson, Sarah M.
    Campbell, Nicholas P.
    Huo, Dezheng
    Artz, Andrew
    Zhang, Yanming
    Gajria, Devika
    Green, Margaret
    Weiner, Howie
    Daugherty, Christopher
    Odenike, Olatoyosi
    Godley, Lucy A.
    Hyjek, Elizabeth
    Gurbuxani, Sandeep
    Thirman, Michael
    Sipkins, Dorothy
    Van Besien, Koen
    Larson, Richard A.
    Stock, Wendy
    LEUKEMIA & LYMPHOMA, 2012, 53 (03) : 445 - 450
  • [39] A Phase I Study of Idarubicin Dose Escalation for Remission Induction Therapy in Acute Myeloid Leukemia
    Lee, Mark
    Kim, Sung-Yong
    BLOOD, 2015, 126 (23)
  • [40] Phase II evaluation of a high-dose mitoxantrone based induction regimen in untreated adults with acute myeloid leukemia
    Feldman, EJ
    Seiter, K
    Traganos, F
    Darzynkiewicz, Z
    Goff, H
    Pozzuoli, M
    Baskind, P
    Santos, S
    Ahmed, T
    LEUKEMIA & LYMPHOMA, 2000, 38 (3-4) : 309 - 315
12345